Literature DB >> 8877149

Selective gamma-chain T-cell receptor gene rearrangements in a patient with Omenn's syndrome: absence of V-II subgroup (V gamma 9) transcripts.

G Mathioudakis1, R A Good, Y Chernajovsky, N K Day, C D Platsoucas.   

Abstract

Only gamma-chain T-cell receptor transcripts utilizing V-1 subgroup gene segments were found in peripheral blood lymphocytes from a patient with Omenn's syndrome. gamma-Chain T-cell receptor transcripts utilizing the V gamma 9 (V-II subgroup) gene segment were absent in peripheral blood lymphocytes from this patient. V gamma 9 J gamma 1.2 C gamma 1 rearrangements are those primarily found in peripheral blood lymphocytes (70 to 85%) from normal donors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877149      PMCID: PMC170420          DOI: 10.1128/cdli.3.5.616-619.1996

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  29 in total

1.  FAMILIAL RETICULOENDOTHELIOSIS WITH EOSINOPHILIA.

Authors:  G S OMENN
Journal:  N Engl J Med       Date:  1965-08-19       Impact factor: 91.245

2.  Two forms of the T-cell receptor gamma protein found on peripheral blood cytotoxic T lymphocytes.

Authors:  M B Brenner; J McLean; H Scheft; J Riberdy; S L Ang; J G Seidman; P Devlin; M S Krangel
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

3.  Monocyte-independent interleukin-2 production and proliferation of human T cells in response to murine hybridomas expressing the OKT3 monoclonal antibody: interleukin-1 is not required for T-cell proliferation.

Authors:  K Itoh; C M Balch; C D Platsoucas
Journal:  Cell Immunol       Date:  1988-08       Impact factor: 4.868

4.  Association of a lymphocyte purine enzyme deficiency (5'-nucleotidase) with combined immunodeficiency.

Authors:  A Cohen; A Mansour; H M Dosch; E W Gelfand
Journal:  Clin Immunol Immunopathol       Date:  1980-02

5.  The Omenn's syndrome: histological, immunohistochemical and ultrastructural evidence for a partial T cell deficiency evolving in an abnormal proliferation of T lymphocytes and S-100 +/T-6 + Langerhans-like cells.

Authors:  L P Ruco; A Stoppacciaro; F Pezzella; M Mirolo; S Uccini; P Barsotti; A M Cassano; A L Boner; L Businco; A Di Fazio
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

6.  Human eosinophil hematopoiesis studied in vitro by means of murine eosinophil differentiation factor (IL5): production of functionally active eosinophils from normal human bone marrow.

Authors:  E J Clutterbuck; C J Sanderson
Journal:  Blood       Date:  1988-03       Impact factor: 22.113

7.  Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985.

Authors:  A Fischer; C Griscelli; W Friedrich; B Kubanek; R Levinsky; G Morgan; J Vossen; G Wagemaker; P Landais
Journal:  Lancet       Date:  1986-11-08       Impact factor: 79.321

8.  Identification of a second T-cell antigen receptor in human and mouse by an anti-peptide gamma-chain-specific monoclonal antibody.

Authors:  C G Ioannides; K Itoh; F E Fox; R Pahwa; R A Good; C D Platsoucas
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

9.  Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody.

Authors:  J Borst; J J van Dongen; R L Bolhuis; P J Peters; D A Hafler; E de Vries; R J van de Griend
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

10.  Evidence of functional lymphocytes in some (leaky) scid mice.

Authors:  G C Bosma; M Fried; R P Custer; A Carroll; D M Gibson; M J Bosma
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  1 in total

1.  A variant of SCID with specific immune responses and predominance of gamma delta T cells.

Authors:  Stephan Ehl; Klaus Schwarz; Anselm Enders; Ulrich Duffner; Ulrich Pannicke; Joachim Kühr; Françoise Mascart; Annette Schmitt-Graeff; Charlotte Niemeyer; Paul Fisch
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.